Insider · CIK 0000939012
Leiv Lea
Files at CRVS (Corvus Pharmaceuticals, Inc.). First filing -, latest -.
In brief
Leiv Lea files SEC Form 4 as CFO at CRVS (Corvus Pharmaceuticals, Inc.). No open-market trade is on file; the transactions below are grants, exercises and other rows that carry no view on the price.
A track record needs three past buys with six months of prices behind them; Leiv Lea has 0, so none is measured yet.
Signals
This insider’s open-market buys and sells, scored.
Transactions
Every row this insider has filed, 3 in all, newest first.
| Date | Company | Transaction | Shares | Price | Value | Holdings after | Filed |
|---|---|---|---|---|---|---|---|
| Dec 4, 2025 | CRVS Corvus Pharmaceuticals, Inc. | AGrant or award Stock Option (Right to Buy)derivative | +400,000 | $0.00 | $0 | 400,000 | Dec 8, 2025 |
| Dec 20, 2024 | CRVS Corvus Pharmaceuticals, Inc. | AGrant or award Stock Option (Right to Buy)derivative | +300,000 | $0.00 | $0 | 300,000 | Dec 23, 2024 |
| Dec 6, 2023 | CRVS Corvus Pharmaceuticals, Inc. | AGrant or award Stock Option (Right to Buy)derivative | +200,000 | $0.00 | $0 | 200,000 | Dec 8, 2023 |
Questions about Leiv Lea
Answered from the filings on this page, as of the latest one.
Is Leiv Lea buying or selling?
Leiv Lea has no open-market buy or sell on SEC Form 4; the filings on record are grants, exercises and other transactions.
How did Leiv Lea's past buys perform?
Not measured yet. InsiderTell needs three past buys with six months of prices to publish a track record, and Leiv Lea has 0.
Where does Leiv Lea file Form 4?
Leiv Lea has filed Form 4 at CRVS (Corvus Pharmaceuticals, Inc.) as Chief Financial Officer. A Form 4 is required of officers, directors and holders of more than 10% of a share class within two business days of a trade.
Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.